RBC Bioscience Corporation (TPEX:6848)
16.25
-0.25 (-1.52%)
Feb 11, 2026, 2:07 PM CST
RBC Bioscience Company Description
RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis Taiwan.
It offers MagCore Plus II Automated Nucleic Acid Extractor, a robotic bench-top workstation for nucleic acid purification; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore® EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-treatment.
The company also provides NGS, genomic DNA, viral nucleic acids, and total RNA kits. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.
RBC Bioscience Corporation
| Country | Taiwan |
| Founded | 1995 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 52 |
| CEO | Mingwei Zhuo |
Contact Details
Address: No. 15, Qiaohe Road New Taipei City, 235029 Taiwan | |
| Phone | 886 2 8912 1200 |
| Website | rbcbioscience.com |
Stock Details
| Ticker Symbol | 6848 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006848005 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Mingwei Zhuo | Chairman and GM |
| Sulan Fang | Accountant and Accounting Supervisor |
| Yen-Liang Chen | Deputy General Manager of Manufacturing Department |
| Kexin Zhan | Deputy General Manager of Management Office |
| Zhengwei Wei | Director of Research & Development |